By Joseph Varon at Brownstone dot org.
In a time when trust in public health is already hanging by a thread, recent revelations from the US Department of Health and Human Services (HHS) have delivered another blow - one that strikes at the very heart of medical ethics.
"Our findings show that hospitals allowed the organ procurement process to begin when patients showed signs of life, and this is horrifying," Secretary Kennedy said. "The organ procurement organizations that coordinate access to transplants will be held accountable. The entire system must be fixed to ensure that every potential donor's life is treated with the sanctity it deserves."
Hidden beneath the surface and quietly ignored by corporate media is a story that should horrify every physician, patient, and policymaker: the commodification of human life in the American transplant system.
The Independent Medical Alliance (IMA), a coalition of physicians dedicated to restoring transparency and patient-centered care, has publicly denounced the findings of a recent HHS report. As President of IMA, I can tell you this: what we've uncovered is not a case of benign negligence. It is a deliberate erosion of the most sacred values in medicine - consent, dignity, and the inviolability of the human body.
A System That No Longer Sees the Patient
Organ transplantation is, in theory, one of the great achievements of modern medicine. When practiced ethically and transparently, it has saved countless lives. But like so many institutions corrupted by profit and policy, it has drifted far from its original mission.
In 2024 alone, over 45,000 organ transplants were performed in the United States. That number should inspire hope - but instead, it invites scrutiny. A substantial portion of those organs were harvested under ethically ambiguous conditions, including donation after circulatory death (DCD) and questionable determinations of brain death. The line between patient and donor is blurring - and not in a way that honors either.
Organ Procurement Organizations (OPOs) are incentivized not by patient outcomes, but by volume. The more organs they harvest, the more funding they receive. Hospitals, too, receive significant reimbursement for transplant procedures, creating a perverse system where terminal patients are seen less as individuals with complex medical stories and more as reservoirs of reusable parts. The New York Times has published a piece that urges standards of death to be liberalized even further.
"We need to figure out how to obtain more healthy organs from donors… We need to broaden the definition of death."
Where Are These Organs Coming From?
The public assumes, understandably, that most organ donors are willing participants - cadaveric donors who've signed cards or checked boxes. But the data doesn't support that rosy picture. A growing percentage of organ procurement comes from patients who are not dead in the traditional sense but are declared brain dead or transitioned to DCD protocols under murky guidelines.
Let's talk plainly: Who decides when a person is truly dead? And how confident are we, as physicians, that our criteria are airtight?
The Trouble with Brain Death
Brain death is defined as the irreversible cessation of all brain activity, including the brainstem. On paper, that sounds final. In practice, it's anything but. There is no universal standard for determining brain death in the United States. Each state, and often each hospital, may have its own protocol.
Here's how it's supposed to be done:
1. Prerequisites:
Establish cause of coma (e.g., trauma, hemorrhage, anoxic injury)
Rule out confounding factors: intoxication, metabolic disturbances, hypothermia
Ensure normothermia, normal electrolytes, and absence of sedatives or paralytics
2. Neurological Exam:
No responsiveness to verbal or noxious stimuli
Absent brainstem reflexes:
Pupillary response to light
Corneal reflex
Oculocephalic reflex ("doll's eyes")
Oculovestibular reflex (cold calorics)
...